As of 2025-09-16, the Relative Valuation of Collegium Pharmaceutical Inc (COLL) is 40.74 USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.92 USD, the upside of Collegium Pharmaceutical Inc based on Relative Valuation is 16.7%.
The range of the Relative Valuation is 21.72 - 62.63 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 20.3x | 19.5x |
| Forward P/E multiples | 20.0x - 22.4x | 21.2x |
| Fair Price | 21.72 - 62.63 | 40.74 |
| Upside | -37.8% - 79.4% | 16.7% |
| Date | P/E |
| 2025-09-15 | 30.33 |
| 2025-09-12 | 32.41 |
| 2025-09-11 | 33.92 |
| 2025-09-10 | 32.75 |
| 2025-09-09 | 32.98 |
| 2025-09-08 | 32.78 |
| 2025-09-05 | 33.28 |
| 2025-09-04 | 34.07 |
| 2025-09-03 | 34.38 |
| 2025-09-02 | 34.01 |
| 2025-08-29 | 33.70 |
| 2025-08-28 | 33.31 |
| 2025-08-27 | 33.69 |
| 2025-08-26 | 33.51 |
| 2025-08-25 | 33.67 |
| 2025-08-22 | 33.97 |
| 2025-08-21 | 34.32 |
| 2025-08-20 | 33.32 |
| 2025-08-19 | 32.68 |
| 2025-08-18 | 33.17 |
| 2025-08-15 | 32.78 |
| 2025-08-14 | 32.27 |
| 2025-08-13 | 32.88 |
| 2025-08-12 | 32.89 |
| 2025-08-11 | 31.39 |
| 2025-08-08 | 30.34 |
| 2025-08-07 | 28.61 |
| 2025-08-06 | 25.84 |
| 2025-08-05 | 27.01 |
| 2025-08-04 | 27.00 |
| 2025-08-01 | 26.11 |
| 2025-07-31 | 25.93 |
| 2025-07-30 | 26.66 |
| 2025-07-29 | 27.10 |
| 2025-07-28 | 27.23 |
| 2025-07-25 | 27.60 |
| 2025-07-24 | 27.89 |
| 2025-07-23 | 28.15 |
| 2025-07-22 | 27.48 |
| 2025-07-21 | 26.84 |
| 2025-07-18 | 27.10 |
| 2025-07-17 | 28.02 |
| 2025-07-16 | 27.59 |
| 2025-07-15 | 27.79 |
| 2025-07-14 | 28.51 |
| 2025-07-11 | 28.24 |
| 2025-07-10 | 28.66 |
| 2025-07-09 | 28.10 |
| 2025-07-08 | 27.42 |
| 2025-07-07 | 26.84 |